Stocks Health care ABEO
NASDAQ · Health careAbeona Therapeutics Inc. (ABEO)
It posted a net loss of $62.9M. In fiscal 2025 capital spending exceeded operating cash flow by $84.3M. At June 30, 2026 it held $56.2M in cash against $15M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What Abeona Therapeutics Inc. does
Abeona Therapeutics Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker ABEO.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $5.8M | $71.2M | $1.01 | -$84.3M |
| 2024 | n/a | -$63.7M | -$1.55 | -$58.5M |
| 2023 | $3.5M | -$54.2M | -$2.53 | -$37.3M |
| 2022 | $1.4M | -$39.7M | -$5.53 | -$43.6M |
| 2021 | $3M | -$84.9M | -$0.86 | -$69.8M |
| 2020 | $10M | -$84.2M | -$0.91 | -$36.4M |
Latest SEC filings
What Abeona Therapeutics Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 15, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026
- August 13, 2026
- July 10, 2026
- June 26, 2026
- June 12, 2026
- June 12, 2026
- June 10, 2026
- June 4, 2026Other event 8-K
Questions about ABEO
What does Abeona Therapeutics Inc. do?
Abeona Therapeutics Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker ABEO.
Is Abeona Therapeutics Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $62.9M.
When did Abeona Therapeutics Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 15, 2026.
Similar companies
Follow ABEO
Get an email when Abeona Therapeutics Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow ABEO: get an email when it filesWhere the numbers come from
Financial figures are the values Abeona Therapeutics Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.